CNN Anderson Cooper 360 March 3, 2022 05:29:00
It can all add up. kesimpta is a once-monthly at-home injection... that may help you put these rms challenges in their place. kesimpta was proven superior at reducing the rate of relapses, active lesions, and slowing disability progression vs aubagio. dont take kesimpta if you have hepatitis b, and tell your doctor if you have had it, as it could come back. kesimpta can cause serious side effects, including infections. while no cases of pml were reported in rms clinical trials, it could happen. ...
Source: archive.org